The crystal structure of 3-(1H-benzo[d]imidazol-2-yl)-7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydroquinolin — dimethylsulfoxide (1/1), C21H19ClFN3O2S

Abstract C21H19ClFN3O2S, monoclinic, P21/n (no. 14), a = 10.1495(4) Å, b = 8.9769(5) Å, c = 22.1431(10) Å, β = 99.901(4)°, V = 1987.43(16) Å3, Z = 4, Rgt(F) = 0.0473, wRref(F2) = 0.1418, T = 293(2) K.

[1]  Raed A. Al‐Qawasmeh,et al.  Design, Synthesis and Qualitative Structure Activity Relationship Evaluations of Quinoline-Based Bisarylimidazoles as Antibacterial Motifs. , 2016, Medicinal chemistry (Shariqah (United Arab Emirates)).

[2]  Richard J. Gildea,et al.  The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment – Olex2 dissected , 2015, Acta crystallographica. Section A, Foundations and advances.

[3]  G. Sheldrick.  SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.

[4]  Jalal A. Zahra,et al.  Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds , 2014, Journal of enzyme inhibition and medicinal chemistry.

[5]  Raed A. Al‐Qawasmeh,et al.  Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs. , 2011, European journal of medicinal chemistry.

[6]  Jalal A. Zahra,et al.  Synthesis and antibacterial activity of 9-cyclopropyl-4-fluoro-6-oxo- 6,9-dihydro-(1,2,5)thiadiazolo(3,4-h)quinoline-7-carboxylic acid and its ethyl ester , 2009 .

[7]  Richard J. Gildea,et al.  OLEX2: a complete structure solution, refinement and analysis program , 2009 .

[8]  L. Mitscher.  Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. , 2005, Chemical reviews.

[9]  Raed A. Al‐Qawasmeh,et al.  Synthesis and properties of some 2,3‐disubstituted 6‐fluoro‐7‐(4‐methyl‐1‐piperazinyl)quinoxalines , 2000 .

[10]  L. Mitscher,et al.  The 2‐pyridone antibacterial agents: bacterial topoisomerase inhibitors , 2000, Medicinal research reviews.